Inspire Medical Systems (INSP)

Executive Summary

Inspire Medical Systems is a commercial-stage medical device company pioneering an innovative, mask-free therapy for obstructive sleep apnea (OSA). Its flagship product, Inspire therapy, is an FDA-approved implantable neurostimulation system that provides a continuous positive airway pressure (CPAP) alternative for patients who cannot tolerate CPAP. The therapy works by stimulating the hypoglossal nerve to maintain airway patency during sleep, effectively addressing moderate-to-severe OSA. With a strong focus on patient outcomes and quality of life, Inspire has carved a unique niche in the sleep medicine market, differentiating itself from traditional mask-based solutions. The company operates primarily in the United States and has seen steady revenue growth driven by expanding prescriber adoption and positive clinical data. Its commercial success is underpinned by robust insurance coverage, including Medicare and major commercial payers, and a growing body of real-world evidence supporting long-term efficacy and safety.

Upcoming Catalysts (preview)

• Q2 2026FDA approval for pediatric OSA indication65% success
• Q4 2026Positive 5-year outcomes data from L1 clinical trial90% success
• Q3 2026Expansion into European or Asian markets via CE mark approval75% success